Hopp til hovedinnhold

Farmakoresistent epilepsi

Sist oppdatert: Sist revidert:
Sist revidert av:
  1. Nakken KO, Taubøll E. Tidsskr Nor Laegeforen. 2009 Oct 8;129(19):1986-9. Review. Norwegian. PMID:19823202 PubMed  
  2. Kwan P, Brodie MJ. Early identification of refractory epilepsy.N Engl J Med. 2000 Feb 3;342(5):314-9.PMID:10660394 PubMed  
  3. Kwan P, Arzimanoglou A, Berg AT, Brodie MJ, Allen Hauser W, Mathern G, Moshé SL, Perucca E, Wiebe S, French J. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies.Epilepsia. 2010 Jun;51(6):1069-77. Epub 2009 Nov 3. Erratum in: Epilepsia. 2010 Sep;51(9):1922. PMID:19889013 PubMed  
  4. Faglige retningslinjer www.epilepsibehandling.no  
  5. Bresnahan R, Gianatsi M, Maguire MJ, Tudur Smith C, Marson AG. Vigabatrin add-on therapy for drug-resistant focal epilepsy. Cochrane Database Syst Rev. 2020 Jul 30;7:CD007302. doi: 10.1002/14651858.CD007302.pub3. PMID: 32730657. PubMed  
  6. Panebianco M, Bresnahan R, Ramaratnam S, Marson AG. Lamotrigine add-on therapy for drug-resistant focal epilepsy. Cochrane Database Syst Rev. 2020 Mar 20;3(3):CD001909. doi: 10.1002/14651858.CD001909.pub3. PMID: 32196639; PMCID: PMC7083514. The Cochrane Library  
  7. Shi LL, Bresnahan R, Martin-McGill KJ, Dong J, Ni H, Geng J. Felbamate add-on therapy for drug-resistant focal epilepsy. Cochrane Database Syst Rev. 2022 Aug 1;8(8):CD008295. doi: 10.1002/14651858.CD008295.pub6. PMID: 35914010 PubMed  
  8. O'Brien TJ, Berkovic SF, French JA, Messenheimer JA, Sebree TB, Bonn-Miller MO, Gutterman DL; STAR 1/STAR 2 Study Group. Adjunctive Transdermal Cannabidiol for Adults With Focal Epilepsy: A Randomized Clinical Trial. JAMA Netw Open. 2022 Jul 1;5(7):e2220189. doi: 10.1001/jamanetworkopen.2022.20189. Erratum in: JAMA Netw Open. 2022 Aug 1;5(8):e2228862. PMID: 35802375 PubMed  
  9. Klein P, Aboumatar S, Brandt C, Dong F, Krauss GL, Mizne S, Sanchez-Alvarez JC, Steinhoff BJ, Villanueva V. Long-Term Efficacy and Safety From an Open-Label Extension of Adjunctive Cenobamate in Patients With Uncontrolled Focal Seizures. Neurology. 2022 Jun 15;99(10):e989–98. doi: 10.1212/WNL.0000000000200792. Epub ahead of print. PMID: 35705501 PubMed  
  10. Laxer KD, Trinka E, Hirsch LJ, Cendes F, Langfitt J, Delanty N, Resnick T, Benbadis SR. The consequences of refractory epilepsy and its treatment. Epilepsy Behav 2014; 37C: 59-70. pmid:24980390 PubMed  
  11. Rogawski MA, Löscher W, Rho JM. Mechanisms of Action of Antiseizure Drugs and the Ketogenic Diet. Cold Spring Harb Perspect Med. 2016 May 2;6(5). PMID: 26801895 PubMed  
  12. Golyala A, Kwan P. Drug development for refractory epilepsy: The past 25 years and beyond. Seizure. 2017 Jan;44:147-156. PMID: 28017578 PubMed  
  13. Brodie MJ. Pharmacological Treatment of Drug-Resistant Epilepsy in Adults: a Practical Guide. Curr Neurol Neurosci Rep. 2016 Sep;16(9):82. PMID: 27443649 PubMed  
  • Karl Otto Nakken, spesialist i nevrologi, dr med
  • Unn Ljøstad, spesialist i nevrologi, professor PhD
  • Åse Mygland, spesialist i nevrologi, professor, dr med